Open Label Trial of Acamprosate in Bipolar Alcoholics
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether acamprosate (Campral) is safe and effective
in treating alcohol dependence in individuals with bipolar disorder. All subjects in the
study must be currently stabilized on mood-stabilizing medication. Half of the subjects will
receive acamprosate in addition to their mood-stabilizing medication; control subjects will
be maintained on their mood-stabilizing medication alone. Measures of alcohol use as well as
mood stability will be obtained weekly throughout the active phase of the study.